Clinical trials in Stara Zagora – page 5

168 clinical trials in Stara Zagora, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Stara Zagora at a glance

168

clinical trials

Research sites1

Quick filters

168 trials in Stara Zagora

Open in trial search

Chronic lymphocytic leukaemia+1

Recruiting

Study on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Study on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Acalabrutinib
Sponsor:Ascentage Pharma Group Inc.

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Long-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis

InvestigationalNo placebo

Long-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:ACP-204 tartrate
Sponsor:Acadia Pharmaceuticals Inc.

Contact Research Centre

Myelofibrosis+1

Recruiting

Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

Registered drugNo placebo

Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Aprepitant
Sponsor:Karyopharm Therapeutics Inc.

Contact Research Centre

Cardiac failure

Recruiting

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Balcinrenone
Sponsor:AstraZeneca AB

Contact Research Centre

Diabetic foot infection

Recruiting

Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

Registered drug

Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Aztreonam
Sponsor:Micurx Pharmaceuticals Inc.

Contact Research Centre

Chronic lymphocytic leukaemia+2

Recruiting

Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

Registered drug

Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Grifols Therapeutics LLC

Contact Research Centre

Axial spondyloarthritis+4

Recruiting

Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

Registered drugNo placebo

Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

Registered drugNo placebo

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Secukinumab
Sponsor:Novartis Pharma AG

Contact Research Centre

Peripheral arterial occlusive disease

Not yet recruiting

Efficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization

Registered drug

Efficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:REGN7508
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Type 2 diabetes mellitus

Not yet recruiting

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Registered drugNo placebo

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Registered drugNo placebo

Bulgaria

Participants:18–64 years
Substances:Insulin Glargine
Sponsor:Novo Nordisk A/S

Contact Research Centre

Obesity

Not yet recruiting

KAI-9531 in Adults With Obesity or Overweight and Diabetes

Investigational

KAI-9531 in Adults With Obesity or Overweight and Diabetes

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:HRS 9531

Contact Research Centre

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Sonelokimab
Sponsor:MoonLake Immunotherapeutics AG

Contact Research Centre

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Stara Zagora

What the registry says about research in the country

01 Inflammatory Conditions

Clinical trials focusing on inflammatory disorders are evaluating novel treatments for conditions including psoriatic arthritis and hidradenitis suppurativa. Researchers are testing innovative therapies targeting specific inflammatory pathways.

Psoriatic Arthritis Studies
Hidradenitis Suppurativa Research
Chronic Rhinosinusitis Treatments

These studies aim to improve quality of life for patients with chronic inflammatory conditions.

02 Respiratory Medicine

Research in respiratory diseases includes multiple trials investigating new treatments for asthma. Studies are examining both established and experimental medications to enhance breathing function and disease control.

Asthma Management
Respiratory Function Studies
Airway Inflammation Research

Emphasis is placed on developing treatments for moderate to severe cases.

03 Oncology and Hematology

Groundbreaking research in blood cancers and solid tumors includes studies on acute myeloid leukemia, chronic lymphocytic leukemia, and prostate cancer. Novel therapeutic approaches are being evaluated.

Leukemia Treatments
Prostate Cancer Therapy
Blood Disorder Management

These trials aim to improve survival rates and treatment outcomes.

04 Neurological Conditions

Studies in neurological disorders are investigating treatments for epilepsy and examining extended-release formulations of existing medications to improve seizure control.

Epilepsy Management
Seizure Control Studies
Drug-Resistant Epilepsy Research

Focus is on developing more effective treatment options for patients with refractory conditions.

Back to Bulgaria All countries